Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) EBITDA (2016 - 2025)

Historic EBITDA for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to -$1.1 million.

  • Milestone Scientific's EBITDA rose 2278.2% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year increase of 13.88%. This contributed to the annual value of -$6.8 million for FY2024, which is 431.26% up from last year.
  • Milestone Scientific's EBITDA amounted to -$1.1 million in Q3 2025, which was up 2278.2% from -$1.5 million recorded in Q2 2025.
  • In the past 5 years, Milestone Scientific's EBITDA ranged from a high of -$984373.0 in Q1 2021 and a low of -$2.9 million during Q2 2022
  • In the last 5 years, Milestone Scientific's EBITDA had a median value of -$1.9 million in 2022 and averaged -$1.8 million.
  • Its EBITDA has fluctuated over the past 5 years, first surged by 3880.58% in 2021, then tumbled by 9448.76% in 2022.
  • Milestone Scientific's EBITDA (Quarter) stood at -$1.6 million in 2021, then decreased by 28.97% to -$2.0 million in 2022, then increased by 1.74% to -$2.0 million in 2023, then dropped by 5.34% to -$2.1 million in 2024, then soared by 45.6% to -$1.1 million in 2025.
  • Its last three reported values are -$1.1 million in Q3 2025, -$1.5 million for Q2 2025, and -$2.0 million during Q1 2025.